The pre-TCRα (pTα) chain is an essential and invariant subunit of the pre-TCR ([@bib62]). The only known physiological function of pTα protein is to associate with nascent TCRβ chains in committed T lineage progenitors to form a functional pre-TCR, which provides essential signals to promote development of αβ thymocytes and to attune αβ/γδ lineage choice. In line with this highly restricted function, pTα expression is largely confined to immature thymocytes. However, pTα message has also been detected in lineage-negative (Lin^−^) BM cells of wild-type and athymic nude mice ([@bib9]), which has given rise to the idea that pTα expression in BM may mark the enigmatic progenitors destined for settling the thymus. So far, neither identity nor full characteristics of thymus settling progenitors (TSPs) have been determined with certainty, leaving an embarrassing gap in our current schemes of T lymphopoiesis ([@bib44]; [@bib5]; [@bib6]; [@bib66]). Characterization of pTα-expressing BM cells, which seem to proffer tantalizing TSP candidates, thus appears imperative.

Cell surface expression of pTα depends on the presence of a functional TCRβ chain and members of the CD3 complex, which may not be available for complex formation at early developmental stages. Moreover, physiological pre-TCR surface expression is too weak to allow purification and further characterization of pre-TCR--positive cells. In an early attempt to overcome this obstacle, a transgenic mouse line was generated, which expressed a human CD25 surface marker (hCD25) under the control of a short regulatory element from the pTα-encoding *Ptcra* locus ([@bib22]). The analysis of such pTα/hCD25 reporter mice resulted in several high-profile publications ([@bib22]; [@bib40]; [@bib31]) reporting the identification and characterization of the common lymphoid progenitor 2 (CLP-2) and the circulating T cell progenitor (abbreviated CTP by [@bib31]), which were commended to comprise physiologically relevant TSPs in BM and blood, respectively. However, these conclusions were based on experiments that did not provide information on to what extent pTα-expressing cells in BM and blood would genuinely contribute to thymopoiesis under in vivo steady-state conditions. Moreover, although a live marker like hCD25 can be useful to identify individual cells with active pTα expression, it does not allow the elucidation of in vivo differentiation pathways and precursor-product relationships. To directly quantify the contribution of pTα-expressing progenitor cells to thymopoiesis and to determine their in vivo commitment status, we have generated a novel knockin mouse line expressing an improved version of Cre recombinase (iCre) under the control of the endogenous *Ptcra* locus. In combination with fluorescent reporter mice, *Ptcra*-controlled iCre expression results in irreversible activation of fluorescent protein expression, providing a heritable lineage marker that indicates current and past *Ptcra* activity. Analysis of our pTα^iCre^ reporter mice revealed highly consistent labeling patterns with recombination of floxed reporter alleles in αβ T lineage cells at near 100% efficiency. Using this in vivo fate mapping system, we reveal a previously unappreciated restriction in the developmental fate of pTα-expressing progenitor populations, arguing against a physiologically relevant CLP-2 stage in T lymphopoiesis. In fact, our data contest any appreciable contribution of cells with a history of pTα expression from BM or blood to canonical pathways of thymopoiesis and thus refute key conclusions from previous studies using conventional pTα/hCD25 reporter mice ([@bib22]; [@bib40]; [@bib31]).

RESULTS
=======

Generation of pTα^iCre^ knockin mice for lineage-tracing experiments
--------------------------------------------------------------------

In vivo lineage tracing based on Cre/loxP technology provides a powerful genetic marking method, which can be used to permanently label specific cell subsets and to directly visualize cell fate decisions in a noninvasive manner within the intact organism ([@bib23]; [@bib8]). To exploit this technique for fate mapping of pTα-expressing progenitor populations, we introduced a mini-gene carrying a codon-optimized version of Cre recombinase (iCre) into the first exon of the pTα-encoding *Ptcra* gene locus ([Fig. 1 A](#fig1){ref-type="fig"}). Particular attention was attached to the design of the construct to assure maximal Cre recombinase expression and activity, while strictly preserving pTα-specific regulation, as described in detail in Materials and methods.

![**Generation of pTα^iCre^ knockin mice.** (A) Targeting strategy. Gray rectangles represent exons; red triangles represent FRT sites. TK indicates the thymidine kinase gene and NEO an expression cassette encoding neomycin resistance. SD and SA mark splice donor and acceptor sites flanking an intron, all derived from the rabbit β-globin locus; ΔATG indicates deletion of the *Ptcra* start codon upon targeted insertion of the iCre-pA cassette. (B) Thymocytes were isolated from mice of the indicated genotypes and analyzed by flow cytometry. Top panels show representative CD4/CD8 profiles of total thymocytes, and bottom panels show corresponding CD44/CD25 profiles of thymocytes pregated on Lin^−^ cells. The total number of thymocytes is shown on top of each panel. Numbers in dot plots indicate percentages of cells in each quadrant. (C) Thymocytes, splenocytes, and lymph node cells were isolated from a pTα^iCre/WT^ × Rosa^RFP/WT^ mouse and a pan-RFP control animal, and expression of the pTα reporter was determined by flow cytometry. Gates in the top panels identify αβ T cells, and blue histograms in the panels below depict pTα reporter expression in gated cells. The gray histograms correspond to αβ T cells from a Rosa^RFP/RFP^ mouse lacking iCre expression as negative control. Pan-RFP refers to a positive control mouse carrying one constitutively activated *Rosa^RFP^* allele. Numbers indicate percentages of cells in each gate. (D) Comparison of labeling efficiencies in T cell compartments of conventional lck-Cre transgenic (*n* = 13) and newly generated pTα^iCre^ knockin mice (*n* = 8) both intercrossed with *Rosa^tdRFP^* reporter mice. Circles correspond to data from individual animals.](JEM_20122609_Fig1){#fig1}

Insertion of the iCre-encoding DNA sequences into the first exon of *Ptcra* was predicted to prevent expression of a functional pTα chain. In line with this prediction, homozygous pTα^iCre^ mice exhibited the same characteristic defects in thymopoiesis ([Fig. 1 B](#fig1){ref-type="fig"}) as described previously for mice lacking functional pTα chains ([@bib19]). Importantly, heterozygous pTα^iCre^ mice were phenotypically indistinguishable from wild-type littermates ([Fig. 1 B](#fig1){ref-type="fig"} and not depicted), confirming the well-established notion that loss of one *Ptcra* allele does not affect T cell development ([@bib19]).

To visualize iCre expression, pTα^iCre^ knockin mice were intercrossed with *Rosa^EYFP^* ([@bib61]) or *Rosa^tdRFP^* ([@bib36]) reporter lines, the choice dependent on compatibility with fluorescent antibodies in multicolor FACS experiments. Both reporter lines gave equivalent results. Cre-mediated excision of a transcriptional stopper resulted in irreversible activation of the respective reporter gene. Importantly, because of the irreversibility of the recombination event, Cre-expressing cells are heritably marked, i.e., all descending cells remain labeled, irrespective of their extant Cre expression status. The majority of αβ T cells depend on pre-TCR--mediated β-selection during their development in the thymus. However, some αβ T cells can mature in the absence of a functional pTα chain ([@bib19]). Thus, it remained to be determined how many αβ T progenitors normally pass through a pTα-expressing stage. Analysis of pTα^iCre^ reporter mice revealed essentially complete labeling of CD3^+^TCRαβ^+^ cells in thymus, spleen, and lymph node ([Fig. 1 C](#fig1){ref-type="fig"}). Pan-RFP or pan-YFP mice carrying a constitutively active reporter allele (see Materials and methods) served as positive control, highlighting near saturation of labeling frequencies in αβ T cells from pTα^iCre^ reporter mice. Importantly, there was no significant variation in labeling efficiencies between individual reporter mice. This is most obvious in comparison with conventional Lck-Cre transgenics ([@bib29]), which may exhibit strong interindividual variation in recombination efficiencies ([Fig. 1 D](#fig1){ref-type="fig"}) and even in lineage fidelity (not depicted), most likely as the result of variegated transgene expression, a phenomenon typical for multicopy transgenes inserted outside their natural genomic context ([@bib41]). Interestingly, much less variation has been observed in a recent systematic study using the same lck-Cre transgenic and Rosa-tdRFP reporter strains ([@bib57]), suggesting a particular vulnerability of the transgenic system to as yet undefined experimental settings. Our pTα^iCre^ knockin mice proved devoid of such problems and thus well suited for lineage-tracing experiments.

History of pTα^iCre^ expression in γδ T cells
---------------------------------------------

Approximately 10--20% of γδ T cells express functional TCRβ chains in the cytoplasm ([@bib18]; [@bib10]; [@bib63]), which have the capacity to associate with pTα chains to form a signaling-competent pre-TCR ([@bib7]). This observation is not easily compatible with models of αβ/γδ lineage determination, which postulate that successful formation of a pre-TCR in uncommitted precursor cells provides an important signal for adoption of an αβ lineage fate ([@bib33]). One possibility to reconcile this inconsistency would be the ad hoc assumption that at least some γδ T cells develop from a pTα-negative precursor population, which cannot form a functional pre-TCR irrespective of TCRβ expression. In fact, there is no need for pTα chains in the γδ lineage, as γδ T cell development proceeds unperturbed in pTα knockout mice ([@bib19]). Although indirect evidence for pTα expression in the γδ lineage exists ([@bib18]; [@bib1]; [@bib63]), the precise number of γδ T cells, which pass through a pTα-expressing developmental stage under physiological in vivo conditions, has not been determined yet.

As shown in [Fig. 2 A](#fig2){ref-type="fig"}, ∼90% of CD3^+^TCRγδ^+^ cells in thymus, spleen, and lymph node are consistently labeled in pTα^iCre^ reporter mice and thus have a history of pTα expression. Approximately the same percentage of reporter-positive cells is found among dendritic epidermal T cells (DETCs; [Fig. 2 B](#fig2){ref-type="fig"}), a specialized γδ T cell population in murine skin ([@bib26]; [@bib25]), which can be readily identified because of the expression of a largely invariant Vγ5Vδ1 TCR (nomenclature according to [@bib28]). The fact that the percentage of DETCs with a history of pTα^iCre^ expression is not significantly reduced in comparison with conventional γδ T cells is noteworthy, as DETCs develop in a single wave from a fetal precursor population beginning on day 14 of gestation ([@bib24]), and thus well before pTα-controlled differentiation of αβ thymocytes.

![**Quantification of past pTα expression in TCRγδ cells.** (A) Dot plots in top row show the gating scheme to identify TCRγδ--expressing cells; the histograms below show the percentage of gated TCRγδ^+^ cells with a history of pTα^iCre^ expression. The underlying gray histograms represent TCRγδ cells from a Rosa^RFP/RFP^ mouse lacking iCre expression as negative control. A pan-RFP mouse (carrying one constitutively active *Rosa^RFP^* allele) was used as positive control. Numbers indicate percentages of cells in each gate. (B) DETCs were isolated from skin as CD3^+^TCRVγ5^+^ cells, and expression of the pTα reporter was assessed by flow cytometry. A nude mouse (*FoxN1^−/−^*) lacking DETCs was included as specificity control for CD3/Vγ5 stainings; other controls as in A. Populations were pregated on CD45^+^ cells. Red histograms refer to pTα reporter expression in gated CD45^+^CD3^+^TCRVγ5^+^ cells. Numbers indicate percentages of cells in each gate. Equivalent results were obtained in two independent experiments. (C) The frequency of reporter-positive cells was compared between TCRαβ^+^ and TCRγδ^+^ cells in thymus (Thy), spleen (Spl), and lymph nodes (Ln). Relevant cell populations were identified by flow cytometry as shown in [Fig. 1 C](#fig1){ref-type="fig"} and panel A. Each data point represents an individual mouse, with green diamonds referring to TCRαβ^+^ and orange circles to TCRγδ^+^ cells. Data were obtained from 12 pTα^iCre/WT^ × Rosa^RFP/WT^ reporter and 8 pan-RFP control mice. (D) The frequency of TCRγδ^+^ cells with intracellular (ic) TCRβ expression in reporter-positive and -negative populations was determined by flow cytometry. Gating for TCRγδ^+^ cells as in A. Numbers indicate percentages of cells in each gate. Data are representative of three independent experiments.](JEM_20122609_Fig2){#fig2}

Although the overwhelming majority of γδ T cells is derived from a pTα-expressing precursor population, we consistently observed reduced labeling frequencies in γδ compared with αβ T cells. In contrast to αβ T cells, which are in essence fully labeled, we found within γδ T cell populations from all organs analyzed a discrete reporter-negative subset of ∼10%. This difference in reporter expression was not caused by lack of *Rosa26* transcription in a specific cell subset, as virtually all γδ T cells were labeled in pan-RFP control mice carrying a constitutively active *Rosa^tdRFP^* allele ([Fig. 2, A and C](#fig2){ref-type="fig"}). Intracellular staining for TCRβ chains revealed that TCRβ-positive γδ T cells were enriched in the reporter-positive rather than reporter-negative γδ T cell subset ([Fig. 2 D](#fig2){ref-type="fig"}). Lack of pTα expression in γδ precursor cells can thus be formally excluded as an explanation for the presence of functional TCRβ chains in a significant percentage of γδ T cells ([@bib7]).

pTα^iCre^ expression is confined to T progenitors lacking B cell, NK cell, and myeloid lineage potential
--------------------------------------------------------------------------------------------------------

If pTα was expressed in a T lineage precursor population with physiologically relevant CLP activity, as suggested previously ([@bib22]; [@bib40]), one should find a significant fraction of B cells, NK cells, and possibly DCs permanently labeled in pTα^iCre^ reporter mice. Although mature CD3^+^ T cells in lymph node and spleen were reporter positive, no cells in the CD19^+^ B cell compartment were labeled ([Fig. 3 A](#fig3){ref-type="fig"}). Even in the thymus, where some B lymphopoiesis occurs in close proximity to T cell development ([@bib2]), the tiny population of mature B cells was consistently reporter negative ([Fig. 3 B](#fig3){ref-type="fig"}). These in vivo findings are incompatible with the view that B cells pass through a pTα^iCre^-expressing precursor stage during normal, steady-state hematopoiesis.

![**pTα^iCre^ expression is confined to the T lineage.** (A) Splenocytes and lymph node cells were isolated from a pTα^iCre/WT^ × Rosa^RFP/WT^ mouse and a pan-RFP control animal, and expression of the pTα reporter was assessed by flow cytometry. Dot plots on top provide the gating scheme for the histograms depicted below. CD3^+^ T cells are shown in blue, CD19^+^ B-cells in green, and cells lacking surface expression of both CD3 and CD19 in yellow. Numbers indicate percentages of cells in each gate. The figure is representative of 13 individual pTα^iCre/WT^ × Rosa^RFP/WT^ and 5 pan-RFP mice. (B) Mature B lymphocytes in lineage-depleted thymic cell populations (see Materials and methods) were identified as CD19^+^IgM^+^ cells (dot plot on top). The histograms below show reporter expression in gated CD19^+^IgM^+^ cells from thymi of a pTα^iCre/WT^ × Rosa^RFP/WT^ mouse (top), a C57BL/6 negative control (middle), and a pan-RFP positive control mouse (bottom). Numbers indicate percentages of cells in each gate. Data are representative of three separate experiments with five individual pTα^iCre/WT^ × Rosa^RFP/WT^ reporter mice. (C) Bar graph indicates the mean percentage of reporter-positive splenocytes (Spl) and lymph node cells within the CD3^−^CD19^−^ population of pTα^iCre/WT^ × Rosa^RFP/WT^ reporter mice (*n* = 13). Error bars indicate SD. (D) Splenocytes and lymph node cells from pTα^iCre/WT^ × Rosa^RFP/WT^ reporter mice on the indicated genetic backgrounds were analyzed for RFP expression. Dot plots on top show the gating scheme, and enlarged histograms below show reporter expression in the corresponding CD3^−^CD19^−^ populations. Numbers indicate percentages of cells in each gate. Data are representative of five separate experiments with a total of five mice of each mutant genotype.](JEM_20122609_Fig3){#fig3}

In the CD3^−^CD19^−^ compartment of spleen and lymph node, which contains NK cells and cells of myeloid descent, we consistently found a small, but discrete population of reporter-positive cells ([Fig. 3, A and C](#fig3){ref-type="fig"}). Importantly, the labeled population completely disappeared both in spleen and lymph nodes when pTα^iCre^ reporter mice were bred on RAG^−/−^ or CD3^−/−^ backgrounds ([Fig. 3 D](#fig3){ref-type="fig"}), formally demonstrating that the development of labeled CD3^−^CD19^−^ cells is entirely dependent on V(D)J recombination and the presence of a functional CD3--TCR complex. A comprehensive phenotypic characterization of the labeled CD3^−^CD19^−^ population for expression of informative cell surface markers and cytoplasmic TCR--CD3 complexes is shown in [Fig. S1](http://www.jem.org/cgi/content/full/jem.20122609/DC1){#supp1}. Staining patterns overlap significantly with those on mature, peripheral αβ T cells, suggesting that reporter-positive CD3^−^CD19^−^ cells in spleen and lymph node may contain a considerable fraction of bona fide T cells, which have internalized their TCR--CD3 complex. A similar explanation has been proposed in a previous study to account for the presence of a reporter-positive, but surface CD3--negative cell population in peripheral lymphoid organs of GFP/TCRδ knockin reporter mice ([@bib46]). However, the observed marker expression is also compatible with the view that a significant fraction of reporter-positive CD3^−^CD19^−^ cells may comprise circulating counterparts of BM T lineage committed intermediate progenitors (CIPs) to be described below. Collectively, the absence of labeled cells in spleen and lymph nodes of RAG- and CD3-deficient pTα^iCre^ reporter mice demonstrates that neither NK cells nor myeloid cells normally pass through a pTα^iCre^-expressing precursor stage.

No evidence for a "lymphoid past" of thymic DCs
-----------------------------------------------

The developmental origin of DC subsets, and in particular their relationship to the lymphoid lineage, has remained a complex and controversial issue ([@bib60]; [@bib34]). For instance, detection of pTα transcripts by RT-PCR in purified mouse plasmacytoid cells and in a subset of thymic DCs has been proposed to indicate a lymphoid past, i.e., a lymphoid developmental origin of these cells ([@bib15]). The analysis of pTα^iCre^ reporter mice does not support such speculations. In the thymus, neither CD11c^+^CD11b^+^ CD11b-type, nor CD11c^+^CD11b^−^ CD8α-type, nor CD11c^+^B220^+^PDCA1^+^ plasmacytoid DC subpopulations contained a significant fraction of reporter-positive cells ([Fig. 4, A and B](#fig4){ref-type="fig"}). Equivalent results were obtained upon analysis of splenic DC subsets (not depicted). Our data demonstrate that pTα expression is no appropriate molecular marker to distinguish DC subpopulations and that DCs are not derived from a pTα^iCre^-expressing precursor population. These observations are fully congruent with recent fate mapping experiments using either Langerin^DTR-EGFP^ or IL-7R^iCre^ knockin mice, which both provided compelling in vivo evidence for a nonlymphoid origin of thymic DCs ([@bib52]; [@bib37]).

![**No evidence for current or past pTα^iCre^ expression in thymic DCs.** (A) Gating scheme to distinguish thymic DC subsets. After digestion of thymi (see Materials and methods), conventional thymic DCs were identified in the resultant single cell suspensions as Lin^−^CD11c^+^MHC class II^high^B220^−^ cells and further fractionated in CD11b-type DCs (purple) and CD8a-type DCs (blue) based on CD11b expression. Plasmacytoid DCs (pDCs; orange) were identified as Lin^−^CD11c^+^MHC class II^low^B220^+^ cells expressing plasmacytoid DC antigen-1 (PDCA1). The underlying gray histogram refers to PDCA1 staining of total thymocytes. Numbers indicate percentages of cells in each gate. (B) Reporter expression in CD11b-type, CD8a-type, and plasmacytoid DCs isolated from thymi of a pTα^iCre/WT^ × Rosa^RFP/WT^ mouse and a pan-RFP control animal. Numbers indicate percentages of cells in each gate. Equivalent results were obtained in three independent experiments with a total of seven pTα^iCre/WT^ × Rosa^RFP/WT^ and three pan-RFP mice.](JEM_20122609_Fig4){#fig4}

Onset of pTα^iCre^ expression in early thymopoiesis
---------------------------------------------------

The observed T lineage--restricted labeling pattern in pTα^iCre^ reporter mice unveils a previously unappreciated link between pTα expression and T lineage commitment, i.e., the complete extinction of all alternative differentiation fates in pTα-expressing progenitor cells. By carefully monitoring reporter expression during early thymopoiesis, we can thus directly visualize the developmental stage at which individual cells have completed T lineage commitment. As shown in [Fig. 5 A](#fig5){ref-type="fig"}, essentially all immature CD4^+^CD8^+^ double-positive (DP) and more mature CD4^+^ or CD8^+^ single-positive thymocytes are reporter positive, demonstrating that all of these αβ T lineage committed cells have gone through a pre-TCR--dependent β-selection step ([@bib27]). In contrast, the CD4^−^CD8^−^ double-negative (DN) compartment contains a significant fraction of cells lacking signs of present or past pTα expression ([Fig. 5 A](#fig5){ref-type="fig"}). Based on CD25 and CD44 expression, the DN population can be subdivided into four developmentally successive stages (DN1--4), with DN2 and DN3 often being further subdivided into developmentally early (E) and late (L) fractions ([@bib11]; [@bib49]). Analysis of these DN subsets in pTα^iCre^ reporter mice reveals a continuous increase in the percentage of labeled cells with progressing maturity ([Fig. 5 B](#fig5){ref-type="fig"}). Although few cells in the DN2E compartment exhibit the pTα expression mark, the number of labeled cells gradually increases to \>97% in the post--β-selection DN4 subset. This labeling pattern demonstrates that T lineage commitment can be completed in some cells as early as DN2. In contrast, most cells in this compartment are reporter negative, consistent with experimental evidence that DN2 contains cells, which, when tested in vitro or in cell transfer assays, can still differentiate along the NK or DC lineages ([@bib56]; [@bib50]; [@bib65]). The observed labeling pattern in pTα^iCre^ reporter mice is fully in line with microarray data provided by the Immunological Genome Project, which identify DN2L cells (Immgen nomenclature, preT.DN2-3) as the first DN subset with detectable pTα message and DN3E (Immgen nomenclature, preT.DN3A) as the subset with highest pTα expression levels.

![**Onset of pTα^iCre^ expression in thymopoiesis.** (A) Total thymocytes of a pTα^iCre/WT^ × Rosa^YFP/WT^ mouse were analyzed by flow cytometry for reporter expression in CD4/CD8 thymocyte subsets. Single-positive (SP), DP, and DN thymocytes were delineated as shown in the dot plot on the left. The underlying gray histograms correspond to thymocytes from a Rosa^YFP/YFP^ mouse lacking iCre expression analyzed in the same experiment with identical gates. (B) Lin^−^ thymocytes (lineage depleted and electronically gated; see Materials and methods) were separated into developmentally successive subpopulations based on CD25 and CD44 expression (top). Color-coded histograms (bottom) show pTα reporter expression in the respective CD25/CD44 subsets. (C) DN1 thymocytes (Lin^−^CD44^+^CD25^−^) were separated into five distinct subsets based on CD24 and Kit expression. Color-coded histograms refer to the respective Kit/CD24 subset in the dot plot above. Combined DN1a + DN1b subsets correspond to ETPs. (D) DN1 and combined DN2 + DN3 thymocyte compartments (top) of pTα^iCre/WT^ × Rosa^RFP/WT^ mice on indicated genetic backgrounds were analyzed by flow cytometry to determine the percentage of reporter-positive cells. Color-coded histograms (bottom) show pTα reporter expression in the respective subsets. Numbers indicate percentages of cells in each gate. (E) Flow cytometric analysis of ETPs for pTα reporter expression using an alternative gating scheme. Arrows indicate the gating hierarchy to identify ETPs, defined as Lin^−^Kit^high^CD44^high^CD25^−/low^ cells. Numbers indicate percentages of cells in each gate. All data are representative of at least three independent experiments.](JEM_20122609_Fig5){#fig5}

The DN1 subpopulation constitutes a heterogeneous mixture of cells, which can be divided into five distinct subsets (DN1a--e) based on surface expression of CD117 (Kit) and CD24 (HSA; [@bib45]). Canonical T cell progenitors are confined to the CD117^high^ subsets DN1a and DN1b ([@bib45]), which correspond to early T lineage progenitors (ETPs), generally considered the earliest intrathymic T lineage precursors ([@bib3]; [@bib4]; [@bib35]). Consistent with lack of reporter expression in DN2E, the DN1a+b/ETP ancestors are reporter negative ([Fig. 5, C and E](#fig5){ref-type="fig"}). In contrast, the vast majority of more mature DN1d and DN1e cells are labeled, and DN1c cells contain reporter-positive and -negative subsets ([Fig. 5 C](#fig5){ref-type="fig"}), indicative of their heterogeneous composition ([@bib45]; [@bib37]). Importantly, when pTα^iCre^ reporter mice were bred on RAG^−/−^ or CD3ε^−/−^ backgrounds, the fraction of labeled cells in DN1 dropped dramatically, whereas the labeling index in combined stages DN2 + DN3 remained high ([Fig. 5 D](#fig5){ref-type="fig"}), indicating that the vast majority of labeled cells within the DN1 compartment are developmentally advanced populations, which are dependent on V(D)J recombination and a functional TCR--CD3 complex. The finding that DN1a+b/ETP populations are homogenously reporter negative ([Fig. 5, C and E](#fig5){ref-type="fig"}) is of key importance because this result effectively excludes all pTα^iCre^-expressing prethymic progenitors as physiologically relevant ETP precursors. The absence of labeling among ETPs is again supported by microarray data from the Immunological Genome Project, which mark the ETP population as negative for pTα expression.

In BM and blood, pTα^iCre^-labeled cells comprise T lineage precursors of an extrathymic maturation pathway
-----------------------------------------------------------------------------------------------------------

pTα-expressing cells in BM and blood have been promoted as physiologically relevant TSP candidates ([@bib22]; [@bib40]; [@bib31]). In accordance with published data on pTα mRNA expression ([@bib9]), we found a small population of reporter-positive cells (1.9 ± 0.5%) within the Lin^−^ BM population of pTα^iCre^ reporter mice ([Fig. 6, A--C](#fig6){ref-type="fig"}). For analysis of BM and blood, we frequently had to switch between *Rosa^RFP^* and *Rosa^YFP^* reporter mice to conform to available fluorescent antibodies. Equivalence of both reporter systems was demonstrated with pTα^iCre^ mice carrying both a *Rosa^RFP^* and a *Rosa^YFP^* allele ([Fig. 6 B](#fig6){ref-type="fig"} and not depicted). As pointed out above, reporter-positive cells cannot be precursors of the thymic ETP population because the latter is homogeneously reporter negative ([Fig. 5, C and E](#fig5){ref-type="fig"}). Although most experimental data favor ETPs as the earliest canonical intrathymic T progenitor population ([@bib3]; [@bib45]; [@bib4]), the formal possibility remains that prethymic cells with a history of pTα expression contribute substantially to thymopoiesis by bypassing the ETP stage. Does the analysis of reporter-positive cells in BM and blood support such a view?

![**Characterization of reporter-positive cells in BM.** (A) Gating scheme to identify reporter-positive cells in Lin^−^ BM. The number in the histogram refers to the percentage of reporter-positive cells. (B) Flow cytometric analysis of dual reporter expression in Lin^−^ BM cells from pTα^iCre/WT^ × Rosa^RFP/YFP^ mice, harboring both an RFP and an YFP reporter allele. Dot plot to the left shows labeling pattern in a representative animal, and the graph to the right summarizes data from 11 animals; each star corresponds to an individual mouse; pregating as in A. (C) Mean percentage of reporter-positive cells in Lin^−^ BM of mice with different genetic backgrounds. Designations below graphs refer to the age of *FoxN1^−/−^* mice in the respective cohort. Error bars denote SD (pTα^iCre/WTxRosaRFP/WT\ or\ YFP/WT^ on WT background, *n* = 15; on *CD3ε^−/−^* background, *n* = 16; on *Rag2^−/−^* background, *n* = 11; on *FoxN1^−/−^* background, younger than 50 d, *n* = 7; on *FoxN1^−/−^* background, 4--6 mo old, *n* = 3). (D) Cell surface phenotype of reporter-positive Lin^−^ cells (green histograms). Black line histograms refer to the expression pattern of the respective surface marker on total Lin^−^ cells (red gate in A). Numbers indicate percentages of cells in each gate. Each histogram is representative of three independent experiments. (E) Kit/Sca-1 and Thy-1/CD2 cell surface phenotype of reporter-positive and -negative Lin^−^ cells. Numbers indicate percentages of cells in each quadrant. Dot plots are representative of two independent experiments. (F) Reporter expression in Lin^−^Thy-1^low/−^ and previously described CTP and CIP populations ([@bib21]). Color codes refer to gated Thy-1/CD2 subsets, as indicated on top of each histogram. Numbers indicate percentages of cells in each gate. Data are representative of at least five animals of each genotype.](JEM_20122609_Fig6){#fig6}

Chemokine receptors CCR7 and CCR9 are critical for efficient homing of TSPs to the thymus ([@bib53]; [@bib32]; [@bib67]). Moreover, all TSP activity in BM and blood has been shown to reside in a Lin^−^ cell subset coexpressing CD27 and CD135 (Flk2/Flt3; [@bib55]; [@bib51]) but lacking Thy-1^high^ and B220^+^ cells ([@bib55]). A significant fraction of fluorescently labeled cells in pTα^iCre^ reporter mice is positive for CCR7 and/or CCR9, and the majority of reporter-positive cells express CD27, as predicted for cells with presumed TSP activity ([Fig. 6 D](#fig6){ref-type="fig"}). However, \>99% of reporter-positive cells lack Flt3 expression, leaving at best spurious numbers of reporter-positive cells as TSP candidates.

pTα^iCre^-labeled Lin^−^ BM cells are ∼99% positive for CD2, and most reporter-positive cells express Thy-1 at very high levels ([Fig. 6, D and E](#fig6){ref-type="fig"}). Lin^−^, Thy-1^high^ BM cells have been described extensively before ([@bib16]; [@bib17]; [@bib13]; [@bib21]). These cells contain firmly T lineage committed progenitors, which have been shown in adoptive transfer experiments to adhere to an extrathymic pathway of T cell maturation ([@bib17]; [@bib21]). Based on CD2 surface expression, Thy-1^high^ cells are divided into two developmentally successive subsets, a CD2^−^CD5^−^CD16^+^CD122^−^ population, termed committed T cell progenitor (CTP), which gives rise in vivo and in vitro within hours to the CD2^+^CD5^+^CD16^−^CD122^+^ subset, termed CIP ([@bib21]). The vast majority of pTα^iCre^-labeled cells reproduce the complete Thy-1^high^CD2^+^CD5^+^CD16^−^CD122^+^ phenotype of CIPs, indicating identity with CIPs.

In pTα^iCre^ reporter mice, ∼0.5--1.0% of CTPs and ∼90% of CIPs are fluorescently labeled ([Fig. 6 F](#fig6){ref-type="fig"}, histograms in second row), a labeling pattern consistent with the reported precursor-progeny relationship between both cell subsets. Moreover, the number of CIPs has been reported to be dramatically reduced in *Rag2^−/−^* and young athymic nude (*FoxN1^−/−^*) mice ([@bib13]). Remarkably alike, pTα^iCre^-labeled cells are virtually absent in *Rag2^−/−^*, *CD3ε^−/−^* and young athymic nude reporter mice ([Fig. 6 F](#fig6){ref-type="fig"}) but gradually reappear on nude background with increasing age, coincident with the reappearance of an increasingly prominent CIP population ([Fig. 6 F](#fig6){ref-type="fig"}, second row from bottom). The absence of labeled cells in pTα^iCre^ reporter mice on *CD3ε^−/−^* and *Rag2^−/−^* backgrounds indicates that survival of pTα-expressing BM progenitors is contingent on prompt pre-TCR--mediated β-selection within the BM, consistent with their proposed extrathymic maturation program.

Analogous observations were made when analyzing pTα reporter expression in peripheral blood of pTα^iCre^ mice. The Lin^−^ blood fraction consistently contained ∼1.0% of reporter-positive cells, which were largely confined to a discrete Thy-1^high^CD2^+^ population with a cell surface phenotype closely resembling the CIP population in BM ([Fig. 7, A and B](#fig7){ref-type="fig"}). Of note, this reporter-positive population was absent in *Rag2*- and *CD3ε*-deficient pTα^iCre^ mice ([Fig. 7 C](#fig7){ref-type="fig"}). In blood of athymic nude mice, the number of both Thy-1^high^CD2^+^ and pTα^iCre^-labeled cells was again, like in BM, age dependent ([Fig. 7 C](#fig7){ref-type="fig"}).

![**Analysis of peripheral blood from adult pTα reporter mice.** (A) Gating scheme to identify reporter-positive cells within the Lin^−^ population (top two panels). Numbers refer to the percentages of cells in the respective gates. Dot plots (bottom) reveal the Thy-1/CD2 surface phenotype of reporter-positive and -negative Lin^−^ blood cells. The numbers refer to the percentage of cells in each quadrant. Data were obtained with pooled blood from eight pTα^iCre/WT^ × Rosa^YFP/WT^ reporter mice and are representative of two independent experiments. (B) Cell surface phenotype of reporter-positive and -negative cell subsets, pregated as shown in A. The open lines in some histograms refer to the expression pattern of the respective surface marker (Kit, B220, Flt3, CD16) on Lin^−^ BM cells, which were stained in the same experiment to provide positive controls. Numbers refer to the percentage of blood cells positive for the respective surface marker. Each histogram is derived from pooled blood of two to three animals and representative of three independent staining experiments. (C) Flow cytometric analysis of pTα reporter expression in Lin^−^ peripheral blood of pTα^iCre/WT^ × Rosa^RFP/WT^ mice bred on the indicated genetic backgrounds. The information in brackets refers to the age of the particular mouse. All cells were pregated on the Lin^−^ population as shown in A. Numbers indicate percentages of cells in each gate. Data are representative of three independent experiments, including all mouse genotypes shown.](JEM_20122609_Fig7){#fig7}

BM progenitors with a history of pTα^iCre^ expression are devoid of TSP activity
--------------------------------------------------------------------------------

The CD135-negative phenotype of reporter-positive cells and their virtual absence in pTα^iCre^ mice on RAG- and CD3ε-deficient backgrounds argue against cells with a history of pTα expression as physiologically important TSPs. To directly assay for TSP activity, we performed competitive complementation transfer assays. Our experimental approach, outlined in [Fig. 8 A](#fig8){ref-type="fig"}, took advantage of the availability of pTα^iCre^ mice with distinct reporter alleles (Rosa^RFP^ and Rosa^YFP^). In brief, Lin^−^RFP^+^ and Lin^−^YFP^+^ cells were sorted from BM of pTα^iCre/WT^ × Rosa^RFP/WT^ and pTα^iCre/WT^ × Rosa^YFP/WT^ reporter mice, respectively. For subsequent use as competitor population, we also sorted the complementary Lin^−^ BM fractions completely devoid of RFP^+^ or YFP^+^ cells, respectively (for sorting gates, see [Fig. S2](http://www.jem.org/cgi/content/full/jem.20122609/DC1){#supp2}). Approximately 7,000 sorted RFP^+^ cells were mixed with 350,000 Lin^−^YFP^−^ competitor cells and injected i.v. into nonirradiated *Il7ra*-deficient mice, whose thymi have been shown to be highly receptive for T progenitor settling independent of irradiation ([Fig. 8 A](#fig8){ref-type="fig"}, left; [@bib47]). In an analogous fashion, we tested sorted Lin^−^YFP^+^ BM cells in competition with Lin^−^RFP^−^ BM cells ([Fig. 8 A](#fig8){ref-type="fig"}, right). Importantly, the injected ratio between test and competitor population (7,000:350,000 = 2%) was chosen to appropriately reflect the actual abundance of each subset in BM of pTα^iCre^ reporter mice ([Fig. 6, B and C](#fig6){ref-type="fig"}). The relative contribution of test versus competitor population to thymopoiesis was evaluated by analyzing the origin of DP thymocytes 2 wk after transfer, a time point sufficiently early to allow direct capture of the most proximal progenitor activity, as established in previous studies with *Il7ra*-deficient recipients ([@bib55]; [@bib51]). As DP thymocytes exhibit a history of pTα expression ([Fig. 5 A](#fig5){ref-type="fig"}), donor-derived DP thymocytes can be easily identified as fluorescent cells. Moreover, the observed ratio between RFP^+^ and YFP^+^ DP cells directly reveals the relative contribution of test versus competitor population. Two independent transfer experiments gave exactly the same results ([Fig. 8, B and C](#fig8){ref-type="fig"}). In all recipient mice successfully reconstituted with RFP^+^ test/YFP^−^ competitor cells, 100% of donor-derived DP thymocytes were YFP^+^, whereas no RFP^+^ thymocytes were detectable, indicating exclusive contribution of reporter-negative BM cells to thymopoiesis. An analogous, complementary set of data were obtained in mice injected with a mixture of YFP^+^ test and RFP^−^ competitor cells, again demonstrating exclusive contribution of reporter-negative BM cells to thymopoiesis ([Fig. 8, B and C](#fig8){ref-type="fig"}). These results effectively refute the possibility that cells with a history of pTα^iCre^ expression contain physiologically relevant TSP activity.

![**pTα^iCre^-labeled BM cells lack TSP activity.** (A) Outline of the competitive complementation transfer experiment. Approximately 7,000 Lin^−^RFP^+^ cells sorted from pooled BM of female pTα^iCre/WT^ × Rosa^RFP/WT^ mice were mixed with ∼350,000 Lin^−^YFP^−^ cells sorted from pooled BM of female pTα^iCre/WT^ × Rosa^YFP/WT^ mice and injected i.v. into an unconditioned IL-7Rα^−/−^ female mouse (left). In the reciprocal experiment, ∼7,000 Lin^−^YFP^+^ cells sorted from pooled BM of the pTα^iCre/WT^ × Rosa^YFP/WT^ mice were mixed with ∼350,000 Lin^−^RFP^−^ cells sorted from pooled BM of the pTα^iCre/WT^ × Rosa^YFP/WT^ mice and also injected i.v. into an unconditioned IL-7Rα^−/−^ female mouse (right). On day 14 after injection, thymocytes of recipient mice were isolated and analyzed for the ratio of red versus yellow donor cells in CD4/CD8 thymic subsets. (B) Cytofluorometric analysis of recipient thymi from two representative IL-7R^−/−^ mice, reconstituted i.v. with a mixture of RFP^+^/YFP^−^ (left) or YFP^+^/RFP^−^ (right) Lin^−^ donor BM cells 14 d earlier. Total numbers of recovered thymocytes were 37 × 10^6^ and 28.4 × 10^6^, respectively. Two independent experiments gave identical results: fluorescently labeled thymocytes were derived exclusively (100%) from the reporter-negative donor cell fraction in 4/4 recipients of RFP^+^/YFP^−^ and in 7/7 recipients of YFP^+^/RFP^−^ Lin^−^ cells. (C) Total number of thymocytes in IL-7R^−/−^ recipients 14 d after receiving RFP^+^/YFP^−^ (open circles) or YFP^+^/RFP^−^ Lin^−^ cells (closed circles). Control recipients were injected with PBS only (closed triangles).](JEM_20122609_Fig8){#fig8}

DISCUSSION
==========

Detection of pTα message in Lin^−^ BM cells of wild-type and athymic nude mice has given rise to speculation that such cells may belong to the long-sought, but still elusive TSP population ([@bib9]). Several publications, all based on a single line of transgenic reporter mice, seemed to provide experimental support to this view ([@bib22]; [@bib40]; [@bib31]). The reporter, encoding an hCD25 surface marker under the control of a short (9 kb) pTα promoter fragment randomly inserted into the mouse genome as multicopy transgene, was found to mark small cell subsets in BM and blood, which were proposed to represent physiologically meaningful maturation stages between the CLP and early intrathymic precursor populations. However, the conclusions were based on cell transfer and in vitro differentiation assays and did not provide information to what extent pTα-expressing cells in BM and blood genuinely contribute to thymopoiesis under in vivo steady-state conditions. The present lineage-tracing study was designed to fill this knowledge gap. To our surprise, our data turned out to refute major findings and key conclusions of the aforementioned studies.

In mature cells, we found pTα^iCre^-mediated labeling strictly confined to the T lineage. No labeled cells were observed in lymph node, spleen, BM, and blood when reporter mice were bred on RAG- or CD3ε-deficient genetic backgrounds, demonstrating complete lack of pTα^iCre^ expression in cells with in vivo NK or myeloid differentiation fates. Also plasmacytoid and thymic DCs were reporter negative, and no labeled B lymphocytes were observed. Our fate mapping data thus highlight pTα as an exquisitely T lineage--specific marker, whose expression indicates firm commitment, perfectly consistent with its restricted physiological function in T committed precursor cells.

The failure to detect labeled cells outside the T lineage necessarily implies the absence of pTα^iCre^ expression in cells with physiologically relevant CLP activity. This result is in striking contrast to the concept of a pTα-expressing CLP-2 stage in early T lymphopoiesis. CLP-2 cells have been identified in BM of pTα/hCD25 transgenic mice as an hCD25^+^B220^+^Kit^−^ population with efficient thymic immigration ability and robust CLP activity ([@bib22]; [@bib40]). Based on these data, we expected to find at least some labeled B, NK, or DCs in pTα^iCre^ reporter mice, which was clearly not the case. We conclude that either B220^+^Kit^−^ CLP-2 cells do not exhibit CLP activity in vivo or cells with CLP activity within the CLP-2 population do not express pTα at significant levels, which would seem paradoxical because pTα/hCD25 reporter expression is the defining feature of these cells and led to their identification in the first place.

What could be the basis for this striking discrepancy between our results and data obtained with conventional pTα/hCD25 reporter mice? Evidence suggests that aberrant expression of the transgenic hCD25 reporter may account for much of the confusion. Although we have targeted our sensitive enzymatic reporter (iCre) into the endogenous *Ptcra* gene locus to preserve all known and unknown genetic elements possibly controlling physiological pTα expression, the hCD25 reporter was inserted randomly into the mouse genome as multicopy transgene. Moreover, reporter expression was controlled by just 9 kb of pTα 5′-flanking sequence, unlikely to contain all cis-regulatory elements required for faithful genetic and epigenetic regulation of pTα expression at all developmental stages from HSCs to mature T cells. Transgene copy number, genomic insertion site and a phenomenon termed transgene variegation are infamous for insidiously perturbing expression of conventional transgenes ([@bib41]; [@bib42]). With regard to the CLP-2, one can thus imagine a scenario in which a few marker-positive cells, devoid of CLP activity, coexpress pTα, accounting for positive RT-PCR results at the population level, whereas the majority of hCD25^+^ CLP-2 cells are aberrantly labeled, lacking endogenous pTα expression, but exhibiting CLP activity. The reported aberrant expression of the huCD25 reporter in 30% of thymic TCRγδ cells and in B lineage committed CD19^+^ cells, clearly negative for endogenous pTα message ([@bib22]; [@bib40]), supports this explanation.

Importantly, and in agreement with hCD25 reporter studies ([@bib22]; [@bib40]), we do find Lin^−^ cells with a history of pTα expression in BM of pTα^iCre^ reporter mice, which are mostly Kit^−^ and a few of which even express B220 ([Fig. 6 D](#fig6){ref-type="fig"}), reminiscent of the CLP-2 surface phenotype. However, labeled cells are absent in mice on *Rag2^−/−^* or *CD3ε^−/−^* genetic backgrounds, indicating that BM cells with a history of pTα expression pass through an obligatory extrathymic β-selection stage and thus cannot serve as precursors of early thymopoiesis. We further validated this conclusion in competitive complementation transfer assays, which demonstrated that pTα^iCre^-labeled BM cells do not contribute to thymopoiesis to any measurable extent ([Fig. 8](#fig8){ref-type="fig"}). In fact, our data strongly suggest that BM cells with a history of pTα^iCre^ expression are largely identical with CIPs, which arise from CTPs and represent a T lineage committed population that belongs to an extrathymic pathway of maturation ([@bib21]).

In agreement with data obtained from the analysis of huCD25 reporter mice ([@bib31]), we do find Lin^−^ cells with a history of pTα expression in peripheral blood of adult pTα^iCre^ reporter mice on wild-type as well as nude background. These cells closely resemble in surface phenotype pTα^iCre^-labeled cells in BM, suggesting that they represent circulating counterparts of CIPs. The vast majority of labeled cells in adult blood belong to a discrete Thy-1^high^CD2^+^ population ([Fig. 7 A](#fig7){ref-type="fig"}). Although labeled cells completely lack B220 and Flt3 surface expression, a substantial fraction stains positive for IL-7Rα and Sca-1 ([Fig. 7 B](#fig7){ref-type="fig"}). A population of Thy-1^high^Sca-1^+^IL-7Rα^+^B220^−^Flt3^−^ cells has been identified in pTα/hCD25 transgenic mice based on hCD25 reporter expression. The cells, termed circulating T cell progenitors (also abbreviated CTPs) were shown to be T committed and claimed to represent "T cell precursors linking extrathymic with intrathymic lymphopoiesis in adult mice" ([@bib31]). Our data do not support this conclusion because all cells with a history of pTα^iCre^ expression disappear in knockin reporter mice when bred on *Rag2^−/−^* or *CD3ε^−/−^* backgrounds. Circulating T cell progenitors (also abbreviated CTPs) described by [@bib31] and CTPs described by [@bib16], [@bib17], and [@bib21] may thus not just share acronyms, but represent cells of the same extrathymic maturation pathway. Collectively, our data refute the concept of pTα expression as a marker for cells with physiologically relevant TSP activity tout ensemble. Instead, we propose that pTα-expressing cells in BM and adult blood belong to an extrathymic pathway of T cell maturation, similar to pTα-expressing cells in gut and liver ([@bib9]), which would also not be considered TSP candidates. To what extent T lineage committed progenitors in fetal blood ([@bib48]), which contain pTα-expressing cells ([@bib9]), are en route to the thymus remains to be investigated.

Two more issues may merit brief discussion. First, our lineage-tracing study provides conclusive evidence that ∼90% of CD3^+^TCRγδ^+^ cells in thymus, spleen, and lymph nodes pass through a pTα-expressing developmental stage. The demonstration of pTα expression in γδ progenitors as such may not come as a surprise because earlier experiments have provided correspondent hints. For instance, an augmented frequency of in-frame TCRβ rearrangements in γδ T cells has been suggested to indicate pre-TCR--mediated β-selection in the γδ lineage ([@bib18]). In line, intracellular TCRβ expression in a fraction of TCRγδ^+^ thymocytes was reported to correlate with increased proliferation ([@bib63]). Although the latter finding has been disputed in another study using pTα^−/−^ mice ([@bib1]), pTα deficiency was observed to correlate with an increased percentage of intracellular TCRβ^+^ γδ cells, again suggesting pre-TCR--mediated effects on the γδ lineage. Although all these studies point to pTα expression in at least some γδ progenitors, our data provide not only direct proof in mice with unperturbed T lymphopoiesis, but also for the first time a precise in vivo quantification. Whether the consistently observed absence of pTα^iCre^ labeling in ∼10% of TCRγδ cells delineates a functionally distinct γδ subset or simply indicates stochastic deviation of a fixed percentage of γδ progenitors from the common αβ/γδ developmental path before initiation of pTα expression is currently under investigation.

Finally, the strict T lineage specificity of pTα^iCre^ expression commends our knockin mice as a novel tool for the conditional genetic modification of αβ T lineage cells. So far, T lineage--specific gene inactivation has been dependent on the availability of mice carrying randomly inserted Cre transgenes, like lck-Cre transgenics ([@bib29]), which suffer from problems inherent in classical transgenesis. In contrast, pTα^iCre^ knockin mice afford consistent recombination efficiencies of essentially 100%, do not violate lineage fidelity, and do not exhibit significant interindividual variation neither in efficacy nor pattern of recombination. This advantageous combination of favorable features should make pTα^iCre^ knockin mice a preferred tool for studies requiring faithful and proficient T lineage--specific gene modification.

MATERIALS AND METHODS
=====================

### Generation of pTα^iCre^ knockin mice.

To achieve optimal concordance between pTα expression and Cre activity, we opted for a knockin approach and constructed a targeting vector, which upon homologous recombination would insert a Cre recombinase--encoding expression cassette into the first exon of the pTα-encoding *Ptcra* locus ([Fig. 1 A](#fig1){ref-type="fig"}, top). To optimize pTα-controlled expression of Cre recombinase, the expression cassette was designed as a mini-gene, containing a splice donor site (SD), a short intron, a splice acceptor site (SA), a cDNA encoding Cre recombinase with its translational stop codon, and an SV40-derived polyadenylation signal (pA) for efficient termination of transcription. The short intronic sequence derived from the rabbit β-globin locus along with appendant splice sites ([@bib30]) was included to allow splicing of the primary transcript, which is known to boost transcription, translation ([@bib43]), and nuclear export ([@bib38]) of eukaryotic mRNA. A codon-optimized, improved version of Cre recombinase, termed iCre, was chosen to further enhance pTα-controlled marker activity ([@bib58]). The SV40-derived polyadenylation signal was inserted immediately downstream of the translational termination codon to impede transcription of subsequent pTα exons and formation of an pTα^iCre^ chimeric message, prone to become susceptible to nonsense-mediated decay caused by the position of the iCre stop codon upstream of exon/exon junctions ([@bib12]). A restriction map and the complete nucleotide sequence of the final targeting vector (pHL-IE), which was constructed using classical recombinant DNA technology, can be obtained from H.J. Fehling upon request. Gene targeting experiments were performed in embryonic day (E) 14.1 embryonic stem cells using G418/Ganciclovir double selection as described previously ([@bib39]). Five independent embryonic stem cell clones with correctly targeted *Ptcra* alleles were identified after screening a total of 400 doubly resistant colonies by PCR. Correct homologous recombination was confirmed by Southern blotting with a probe located outside of the targeting construct. To exclude unpredictable effects of the *Neo* gene and its associated strong enhancer/promoter elements on the expression pattern of the targeted *Ptcra* locus, the FRT-flanked Neomycin selection cassette was excised in vitro by Flp-mediated recombination in one of the correctly targeted clones (E14-IE44). Embryonic stem cells of a *Neo*-deficient subclone (E14-IE44ΔNeo2) were used to generate pTα^iCre^ knockin mice according to conventional methodology. Unless stated otherwise, all data shown are from animals 6--14 wk old and backcrossed for at least 10 generations onto C57BL/6 background.

### Other mice.

Lck-Cre mice (B6.Cg-TgN(Lck-Cre)548Jxm ([@bib29]) were purchased from the Jackson Laboratory, IL-7Rα^−/−^ mice (B6.129S7-Il7r^tm1Imx^/J) from Charles River, CD3ε^−/−^ mice (C57BL/6-Cd3ε^tm1Mal^/Orl; EMMA ID: EM:00047) from the European Mouse Mutant Archive, and *Rag2^−/−^* mice (B6.SJL(129S6)-Ptprc^a^Rag2^tm1Fwa^/Boy/Cr/Tac) from Taconic. *Rosa^tdRFP^* and *Rosa^EYFP^* reporter mice have been described previously ([@bib61]; [@bib36]). Pan-RFP and pan-YFP mice carry constitutively active reporter alleles and were generated by intercrossing *Rosa^tdRFP^* or *Rosa^EYFP^* reporter mice with animals from a germline Cre-deleter strain ([@bib54]). Offspring in which the Rosa26-driven fluorescent reporter had been activated irreversibly as the result of Cre/loxP-mediated recombination in the germline were backcrossed for several generations onto C57BL/6, thereby eliminating the Cre recombinase transgene. Animals carrying one constitutively active reporter allele were used as controls in all experiments to indicate the maximal percentage of labeled cells detectable within the cell population of interest and to reveal any potential toxicity of the fluorescent markers for the particular cell subset of interest. All mice were bred and housed in individually ventilated cages in the mouse facility of the University of Ulm. All experiments involving the manipulation of mice were approved by the Regierungspräsidium Tübingen.

### Flow cytometry.

Single cell suspensions from thymus, spleen, lymph nodes, and BM were prepared by mechanical dissociation of respective tissues and passage of cells through a 70-µm filter. For spleen and BM, red blood cells were lysed with ACK solution (150 mM ammonium chloride, 1 mM potassium bicarbonate, and 0.1 mM EDTA). Fc receptors were blocked by incubating cells in staining buffer (PBS supplemented with 5% heat-inactivated FCS) with anti-CD16/CD32 antibodies (Fc-Block; BD) and purified mouse IgG (Jackson ImmunoResearch Laboratories, Inc.). All stainings were performed in staining buffer on ice for 30 min with optimal dilutions of commercially prepared antibodies. Intracellular staining for TCRβ, TCRγδ, and CD3ε was performed using the Cytofix/Cytoperm kit (BD) according to the manufacturer's instruction. A complete list of all antibodies used in the study is shown in [Table S1](http://www.jem.org/cgi/content/full/jem.20122609/DC1){#supp3}. In all experiments, Sytox Blue (Invitrogen) was added before analysis to mark dead cells. Cells were acquired on a FACSCanto II (BD) or FACSAria II (BD) with electronic gates set on live cells by a combination of forward/side scatter and Sytox Blue exclusion. Doublets were systematically excluded based on forward and side scatter area versus width parameters. Data were analyzed using mostly Diva (BD) and sometimes (for overlays) FlowJo software (Tree Star). Specific procedures for the isolation and cytofluorometric analysis of particular cell subsets are given below.

### Analysis of thymic DCs.

DCs were isolated as published ([@bib20]). In brief, thymi were minced with scissors into small pieces and digested in 1 ml PBS containing 0.2 mg/ml Collagenase D (Roche), 0.1 mg/ml Dispase I (Roche), and 25 mg/ml DNase I (Sigma-Aldrich) for 10 min at 37°C while shaking in a thermomixer at 800 rpm. The supernatant containing released cells was collected, and enzymatic activities were inhibited by adding an equal volume of PBS containing 5% FCS and 5 mM EDTA. Additional cells were collected by four to five rounds of repeated tissue digestion and harvest. Pooled cells were counted, and three million cells were stained with a mixture of biotinylated antibodies directed against CD3 (500A2), CD4 (GK1.5), CD19 (1D3), TER119, and CD49b (DX5) and the following DC-specific antibodies: anti--CD11c-APC-Cy7 (N418), anti--CD11b-PE-Cy7, anti--MHC class II--APC (M5/114.15.2), anti--B220-PE-Cy5.5 (RA3-6B2), and anti--PDCA1-FITC (eBio-927). Cells stained with biotinylated antibodies were revealed by secondary staining with Streptavidin--eFluor 450 and electronically excluded. DC subsets were identified within the eFluor 450--negative cell fraction as CD11c^+^MHC class II^high^B220^−^CD11b^−^ lymphoid DCs (lyDCs), CD11c^+^MHC class II^high^B220^−^CD11b^+^ myeloid DCs (myDCs) and CD11c^+^MHC class II^low^B220^+^PDCA1^+^ plasmacytoid DCs according to reported surface phenotypes ([@bib14]; [@bib64]). The designation lyDC or myDC originally referred to the suggested origin of these DC populations from lymphoid or myeloid pathways, respectively. LyDCs are also named CD8^+^ and myDCs CD8^−^ conventional DCs ([@bib59]).

### Analysis of DETCs.

DETCs were isolated from mouse ears, which were minced with scissors into small pieces and digested in 1 ml protease solution (200 mg/ml Collagenase D1, 2 mg/ml Dispase I, and 5 mg/ml DNase I in PBS) for 15 min at 37°C while shaking in a thermomixer at 800 rpm. Supernatant containing released cells was harvested and kept on ice. Remaining tissue was subject to a second round of digestion with fresh protease solution, again for 15 min at 37°C while shaking at 800 rpm. Supernatants of successive digests were pooled and adjusted to 5 mM EDTA to antagonize cell aggregation. After a 5-min incubation period on ice, cells were passed through a 70-µm filter, washed once, and resuspended in staining buffer. Cells were stained with antibodies specific for CD45 (30-F11), CD3 (145-2C11), and Vγ5 (F536).

### Analysis of thymic B cells.

To enrich for thymic B cells, total thymocytes were stained with biotinylated rat antibodies against CD4 (GK1.5) and CD8 (53-6.7) and depleted using anti--rat IgG-conjugated magnetic Dynabeads (Invitrogen) according to the manufacturer's instruction. Remaining cells were stained with Streptavidin--APC-Cy7 (BD), anti--CD19-FITC (1D3), and anti-IgM (1B4B1) antibodies. Mature thymic B cells were identified in the pregated APC-Cy7--negative population as CD19^+^IgM^+^ cells.

### Analysis of DN thymocytes.

To enrich for most immature thymocyte populations, total thymocytes were stained with a mixture of biotinylated antibodies directed against CD3ε (500A2), CD8α (53-6.7), CD11b (M1/70), CD19 (1D3), NK1.1 (PK136), Gr1 (RB6-8C5), TCRβ (H57-597), TCRγδ (GL3), TER119, CD11c (HL3), and B220 (RA-6B2), followed by depletion with Dynabeads according to the manufacturer's instruction. Remaining cells were stained with directly conjugated antibodies against relevant surface molecules and always with a second anti-CD3ε--specific antibody (145-2C11) as well as with Streptavidin-QDot605 to facilitate gating on the Lin^−^ population and to permit electronic exclusion of remaining Lin^+^ cells.

### Analysis of Lin^−^ BM cells.

To enrich for Lin^−^ progenitor populations, BM cells were stained with a mixture of biotinylated antibodies directed against CD3ε (500A2), CD8α (53-6.7), CD11b (M1/70), CD19 (1D3), NK1.1 (PK136), GR1 (RB6-8C5), TCRβ (H57-597), TCRγδ (GL3), TER119, and CD11c (HL3), followed by depletion with Dynabeads according to the manufacturer's instruction. Antibodies against CD4 and B220 were deliberately omitted from the lineage mix as relevant precursor populations, like the CLP-2, have been reported to express these surface markers ([@bib40]). Remaining cells were stained with a mixture of directly labeled antibodies against relevant surface molecules, Strepavidin-QDot605, and a second anti-CD3ε antibody (145-2C11) conjugated to APC or APC-Cy7. Streptavidin-QDot605 and the additional anti-CD3ε antibody were used to rigorously exclude Lin^+^ cells, in particular mature T cells, and to facilitate electronic gating on the Lin^−^ population.

### Analysis of progenitors in peripheral blood.

Peripheral blood was drawn from tail veins into EDTA-containing microtubes (Sarstedt). Blood from several mice was pooled, diluted 1:1 with PBS, and carefully underlaid with Ficoll-Paque Plus (GE Healthcare) at a ratio of 3:1 (vol/vol). Samples were centrifuged in a swing-out bucket for 30 min at 20°C. The buffy coat layer was collected and transferred into 10 ml of staining buffer. Cells were pelleted by centrifugation, resuspended in staining buffer, and counted, excluding dead cells with Trypan Blue. Cells were stained with a mixture of biotinylated antibodies directed against the lineage markers CD3 (500A2), CD8α (53-6.7), CD11b (M1/70), CD19 (1D3), NK1.1 (PK136), GR1 (RB6-8C5), TCRβ (H57-597), TCRγδ (GL3), TER119, and CD11c (HL3) and directly labeled antibodies against specific cell surface molecules. Lin^+^ cells were revealed by secondary staining with Streptavidin-QDot605 and electronically excluded. To rigorously exclude reporter-positive T cells and to facilitate electronic gating on Lin^−^ cells, a second anti-CD3 antibody (145-2C11) conjugated to APC was included in each staining. Antibodies against CD4 and B220 were deliberately omitted from the lineage mix.

### Adoptive cell transfer into Il-7Rα^−/−^ recipients (competitive complementation transfer assay).

BM cells from eight female pTα^iCre/WT^ × Rosa^RFP/WT^ and eight female pTα^iCre/WT^ × Rosa^YFP/WT^ mice were stained with the following mixture of biotinylated, lineage-specific antibodies: anti-CD3 (500A2), CD19 (1D3), CD11c (HL3), TCRγδ (GL3), NK1.1 (PK136), TER119, Gr1 (RB6-8C5), and CD11b (M1/70). Stained cells were depleted using anti--rat IgG-conjugated magnetic Dynabeads according to the manufacturer's instruction. Antibodies against CD4 and B220 were deliberately omitted from the lineage mix. Cells from all pTα^iCre/WT^ × Rosa^RFP/WT^ mice remaining after depletion were pooled, as were remaining cells from all pTα^iCre/WT^ × Rosa^YFP/WT^ mice. Both samples were then stained with Streptavidin-QDot605 and CD3-PECy7 (145-2C11) to visualize remaining Lin^+^ cells and to facilitate gating on the Lin^−^ population, respectively. Stained cells from both samples were sorted on a FACSAria IIu, the first sample for Lin^−^RFP^+^ and Lin^−^RFP^−^ cells, the second sample for Lin^−^YFP^+^ and Lin^−^YFP^−^ cells. A small fraction of sorted cells was reanalyzed to ascertain purity. Representative sorting gates and postsort data are shown in Fig. S2. The following number of cells was obtained in two independent experiments: first experiment, 18 × 10^3^ Lin^−^RFP^+^ cells and 0.8 × 10^6^ Lin^−^RFP^−^ cells; 14 × 10^3^ Lin^−^YFP^+^ cells and 1.2 × 10^6^ Lin^−^YFP^−^ cells; second experiment, 32 × 10^3^ Lin^−^RFP^+^ cells and 1.2 × 10^6^ Lin^−^RFP^−^ cells; 25 × 10^3^ Lin^−^YFP^+^ cells and 1.6 × 10^6^ Lin^−^YFP^−^ cells. Lin^−^RFP^+^ cells from pTα^iCre/WT^ × Rosa^RFP/WT^ mice were mixed with Lin^−^YFP^−^ cells from pTα^iCre/WT^ × Rosa^YFP/WT^ mice, and Lin^−^YFP^+^ cells from pTα^iCre/WT^ × Rosa^YFP/WT^ were mixed with Lin^−^RFP^−^ cells from pTα^iCre/WT^ × Rosa^RFP/WT^ mice, each time at a ratio of 1/50 (2%) to correctly reflect the actual abundance of each subset in BM of reporter mice. Mixed tester and competitor cells were injected i.v. into young (6--12 wk old), untreated IL-7Rα^−/−^ recipient females. In the first experiment, we injected each of three recipients with 6 × 10^3^ Lin^−^YFP^+^ + 300 × 10^3^ Lin^−^RFP^−^ cells, and each of two recipients with 7 × 10^3^ Lin^−^RFP^+^ + 350 × 10^3^ Lin^−^YFP^−^ cells. In the second experiment, we injected each of four recipients with 8 × 10^3^ Lin^−^YFP^+^ + 400 × 10^3^ Lin^−^RFP^−^ cells and each of three recipients with 8 × 10^3^ Lin^−^RFP^+^ + 400 × 10^3^ Lin^−^YFP^−^ cells. In each experiment, two recipients were injected with PBS only as negative control. Reconstituted mice were analyzed on day 14 after injection, counting the day of injection as day 0.

### Online supplemental material.

Fig. S1 shows a comprehensive cytofluorometric characterization of pTα^iCre^ reporter--positive cells residing within the splenic and lymph node CD3^−^CD19^−^ population. Fig. S2 depicts the sorting strategy and postsort data for tester and competitor cell subsets, which were used as donor populations for thymic reconstitution of IL-7Rα^−/−^ recipients (competitive complementation assay). Table S1 describes all antibodies used for flow cytometry. Online supplemental material is available at <http://www.jem.org/cgi/content/full/jem.20122609/DC1>.
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